Keyword → MRNA

SLS Surges 17.66%: Unpacking the Catalyst Behind the Stock's Sharp Increase

SLS sees a significant one-day surge. Analysts point to a combination of sector rotation and overlooked earnings potential as key drivers.

FDA's Vinay Prasad to Exit Biologics Post in April, Sending Biotech Stocks Sharply Higher

The announced departure of Dr. Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, triggered a significant rally in biotech equities Monday, with uniQure surging more than 31% in premarket trading. Investors interpreted the news as a signal that the agency may adopt a more predictable and industry-friendly regulatory posture for vaccines, gene therapies, and rare disease treatments.

OPKO Health Schedules Q4 Earnings Report, Shares React to Upcoming Guidance

OPKO Health announced plans to release its fourth-quarter and full-year 2025 financial results later this month, expected to include commentary on future revenue and profitability. The upcoming earnings call could influence sentiment among healthcare and biotech investors amid broader market volatility.

Market Focus Shifts to Jobs, Inflation and Retail Data as Earnings Calendar Warms

Investors are bracing for a key week of economic data and corporate earnings, with delayed January jobs numbers, CPI inflation, and December retail sales due for release. Major technology and consumer firms are also reporting results, highlighting the intersection of macro indicators and corporate performance. These releases are expected to shape expectations for monetary policy and market direction in coming weeks.